Adjuvant capecitabine in resected biliary tract cancer: a real-world data from the BILCAP-Real study (ACABi multicentre cohort).
- DOI
- 10.1016/j.jhepr.2026.101968
- Published
- 2026 Jul 28
- Container
- JHEP reports : innovation in hepatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jhepr.2026.101968,
title = {Adjuvant capecitabine in resected biliary tract cancer: a real-world data from the BILCAP-Real study (ACABi multicentre cohort).},
author = {Noé C and Henriques J and Chanez B and Vernerey D and Lecomte T and Durand A and Assenat E and Edeline J and Heurgué A and Tougeron D and Manfredi S and Hautefeuille V and Neuzillet C and Roth G and Lagasse JP and Tournigand C and Delaye M and Hollebecque A and Turpin A and Parent P},
year = {2026},
journal = {JHEP reports : innovation in hepatology},
doi = {10.1016/j.jhepr.2026.101968},
url = {https://doi.org/10.1016/j.jhepr.2026.101968}
}RIS
TY - JOUR TI - Adjuvant capecitabine in resected biliary tract cancer: a real-world data from the BILCAP-Real study (ACABi multicentre cohort). AU - Noé C AU - Henriques J AU - Chanez B AU - Vernerey D AU - Lecomte T AU - Durand A AU - Assenat E AU - Edeline J AU - Heurgué A AU - Tougeron D AU - Manfredi S AU - Hautefeuille V AU - Neuzillet C AU - Roth G AU - Lagasse JP AU - Tournigand C AU - Delaye M AU - Hollebecque A AU - Turpin A AU - Parent P PY - 2026 JO - JHEP reports : innovation in hepatology DO - 10.1016/j.jhepr.2026.101968 UR - https://doi.org/10.1016/j.jhepr.2026.101968 ER -
APA
C, N., J, H., B, C., D, V., T, L., A, D., E, A., J, E., A, H., D, T., S, M., V, H., C, N., G, R., JP, L., C, T., M, D., A, H., A, T., & P, P. (2026). Adjuvant capecitabine in resected biliary tract cancer: a real-world data from the BILCAP-Real study (ACABi multicentre cohort).. JHEP reports : innovation in hepatology. https://doi.org/10.1016/j.jhepr.2026.101968
Source records
- pubmed · retrieved 2026-09-26T06:46:40.197Z